METHODS FOR TREATING NUCLEAR FACTOR KAPPA LIGHT CHAIN ENHANCER OF ACTIVATED B CELL (NF B) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS
The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa light chain enhancer of activated B cells ("NF ??") in the gut of a host in need thereof and methods of treating conditions related to NF KB dysregulation. The herein invention provides a method for activating NF ?? in the gut of a host in need thereof. The method comprises orally administering an effective amount of a composition consisting essentially of eggshell membrane and/or eggshell membrane isolates and/or eggshell membrane hydrolysates for activation of NF ?? to the host.